Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
Daneng Li(City Of Hope National Medical Center), William Dale(City of Hope)
Cited by 443
Related Papers
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
|The Lancet Oncology|2023|243
Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study
|Supportive Care in Cancer|2017|64
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
|Cell Reports Medicine|2025|12
850 Interim results for phase 1b dose expansion of MTL-CEBPA in combination with pembrolizumab in patients with advanced solid tumour malignancies
|Regular and Young Investigator Award Abstracts|2022|1